CeriBell's AI-powered EEG system offers rapid seizure diagnosis. The stock is undervalued by at least 50% over the long-term, ...

A new treatment option has become available for severe epilepsy: fenfluramine, which is now available on the NHS ...

Any patient suffering from new or worsening medical symptoms hopes for a relatively quick and accurate diagnosis.

Based on alignment gained with FDA under the Regenerative Medicine Advanced Therapy (RMAT) designation, Neurona plans to conduct the Phase 3 ...

NaviFUS is Taiwan's first and only high-end medical device company leveraging advanced chip integration and chip deployment, cementing its leadership in the global market. As the demand for ...

The talent of Wolfgang Amadeus Mozart, the famous Austrian composer, still captivates many audiences. Classical music lovers ...

The NaviFUS system uses transcranial focused ultrasound and therapeutic guidance tracking for drug delivery and neuromodulation, offering new hope for patients with brain cancer and drug-resistant ...

Hundreds of children in England with a rare and severe form of epilepsy are set to benefit from a new drug being rolled out on the NHS. Fenfluramine has been recommended by the National Institute for ...

Biogen Inc. has agreed to pay as much as $550 million to develop and sell a drug to treat a genetic seizure disorder, the ...

In exchange for $165 million, Biogen now has access to zorevunersen, a potential first-of-its-kind treatment for Dravet ...

Stoke Therapeutics Inc. and Biogen Inc. said Tuesday they are entering a collaboration to develop and commercialize a ...

Southern Methodist University biology researchers are uncovering how brain, heart, and lung connections may hold the key to ...